The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Byrnes Robert F since 2014.
The trader's CIK number is 1263175.
At the time of the last reporting, Byrnes Robert F was the Director of Revance Therapeutics, Inc.. (stock ticker symbol RVNC).
Also see all insider trading activities at Revance Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | RVNC | 0 | $0 | 0 | $0 | 10,999 | $42,896 |
| 2014 | RVNC | 0 | $0 | 0 | $0 | 2,666 | $9,597 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-02-12 | RVNC | Option Ex | 10,999 | 3.90 | 42,896 |
| 2014-09-17 | RVNC | Option Ex | 2,666 | 3.60 | 9,597 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Byrnes Robert F (Director of Revance Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.